Plasma fatty acid metabolic profiling coupled with clinical research reveals the risk factors for atherosclerosis development in type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Plasma fatty acid metabolic profiling coupled with clinical research reveals the risk factors for atherosclerosis development in type 2 diabetes mellitus

Published:2019 Issue:62 Volume:9 Page:36162-36170
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Zhou Qianyu¹²³⁴,Ren Dabing¹²³⁴⁵,Xiao Yang⁶⁷⁸⁹¹⁰,Yi Lunzhao¹²³⁴⁵^ORCID,Zhou Zhiguang⁶⁷⁸⁹¹⁰

Affiliation:

1. Faculty of Agriculture and Food

2. Kunming University of Science and Technology

3. Kunming

4. China

5. Yunnan Food Safety Research Institute

6. Diabetes Center

7. Institute of Metabolism and Endocrinology

8. Department of Endocrinology

9. The Second Xiangya Hospital

10. Central South University

Abstract

FFAs metabolic profiling and clinical research were combined to reveal the risk factors for atherosclerosis development in T2DM patients.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2019/RA/C9RA07634D

Reference42 articles.

1. Metabolomics for clinical use and research in chronic kidney disease

2. Metabolomics: A tool for early detection of toxicological effects and an opportunity for biology based grouping of chemicals—From QSAR to QBAR

3. Tissue-specific toxicological effects of cadmium in green mussels (Perna viridis): Nuclear magnetic resonance-based metabolomics study

4. Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase

5. Effect of Anagliptin on Glycemic and Lipid Profile in Patients With Type 2 Diabetes Mellitus

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood-Derived Lipid and Metabolite Biomarkers in Cardiovascular Research from Clinical Studies: A Recent Update;Cells;2023-12-08